| |
| | Cancer Information | UPMC Cancer Centers |
 | | Neurocognitive late effects most commonly follow treatment of malignancies that require central nervous system (CNS)-directed therapies, such as cranial radiation or intraventricular/intrathecal (IT) chemotherapy; thus, children with CNS tumors, head and neck sarcomas, and acute lymphoblastic leukemia (ALL) are most commonly affected. |
 | | [16] Another study evaluated quantitative tissue volumes from magnetic resonance imaging scans, correlating these results with neurocognitive assessments for 40 long-term survivors of pediatric brain tumors treated with radiation therapy with or without chemotherapy 2.6 to 15.3 years earlier (median, 5.7 years) at an age of 1.7 to 14.8 years (median, 6.5 years). |
 | | Moreover, tumor-related deficits because of direct invasion of the brain, seizures, and hydrocephalus must be recognized. |
| www.upmccancercenters.com /pdq_xml/cancer.cfm?cdrid=CDR0000343584 (11542 words) |
|